How Prescription Digital Therapeutics Can Help Solve the Nation’s Diabetes Epidemic
Dr. Mark Berman, Chief Medical Officer of Better Therapeutics discusses how prescription digital therapeutics (PDTs) could reimagine how we treat type 2 diabetes and how our current system of treatment doesn’t work for more than half of patients. While standard of care focuses on treating symptoms, PDTs can enable physicians to focus treatment on behaviors that lead to the disease of type 2 diabetes. He talks about the company’s type 2 diabetes PDT candidate BT-001 and its recent positive primary endpoint data readout, physicians’ support of BT-001 to date, and its pathway to De Novo clearance.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Diabetes. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Diabetes and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Diabetes?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
Key Takeaways
- Key Point: Mark Berman, Chief Medical Officer of Better Therapeutics discusses how prescription digital therapeutics (PDTs) could reimagine how we treat type 2 diabetes and how our current…
- Key Point: While standard of care focuses on treating symptoms, PDTs can enable physicians to focus treatment on behaviors that lead to the disease of type 2 diabetes.
- Key Point: He talks about the company’s type 2 diabetes PDT candidate BT-001 and its recent positive primary endpoint data readout, physicians’ support of BT-001 to date, and its pathway t…
- Key Point: Mark Berman serves as Better’s Chief Medical Officer.
- Key Point: Previously, he practiced as an internal and lifestyle medicine physician at One Medical.
Dr. Mark Berman serves as Better’s Chief Medical Officer. Previously, he practiced as an internal and lifestyle medicine physician at One Medical. Dr. Berman received his M.D. from Yale. He completed residency at Harvard’s Brigham and Women’s Hospital and a clinical research fellowship at University of California, San Francisco. He has also served as a director of the American College of Lifestyle Medicine.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.


